Arcadia Biosciences

Quarterly Financials

Values in thousands 2024-09-30 2024-06-30 2024-03-31 2023-12-31
Revenue
$1,537
$1,306
$1,255
$1,170
Gross Profit
505
673
435
500
EBITDA
-1,760
-1,986
-2,975
-3,033
EBIT
-1,767
-2,020
-3,203
-3,076
Net Income
-1,612
1,061
-2,423
-2,853
Net Change In Cash
1,537
1,306
1,255
1,170
Free Cash Flow
248
-2,459
-3,223
-4,196
Cash
3,936
5,504
3,317
6,518
Basic Shares
1,363
1,362
1,361
1,285

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue
$5,330
$9,956
$6,780
$8,034
Gross Profit
2,030
154
-1,928
2,835
EBITDA
-13,938
-13,647
-23,267
-5,441
EBIT
-14,225
-15,010
-24,311
-6,103
Net Income
-13,981
-15,612
-16,134
-6,026
Net Change In Cash
5,330
9,956
6,780
8,034
Cost of Revenue
7,626
Free Cash Flow
-15,299
-14,049
-26,875
-32,553
Cash
6,518
20,644
28,685
14,042
Basic Shares
1,236
599
532
248

Earnings Calls

Quarter EPS
2024-09-30
-$0.87
2024-06-30
$0.78
2024-03-31
-$1.78
2023-12-31
-$2.52